Qingle Ma

1.7k total citations
31 papers, 1.3k citations indexed

About

Qingle Ma is a scholar working on Immunology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Qingle Ma has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 13 papers in Molecular Biology and 11 papers in Biomedical Engineering. Recurrent topics in Qingle Ma's work include Extracellular vesicles in disease (9 papers), Immunotherapy and Immune Responses (8 papers) and Immune cells in cancer (8 papers). Qingle Ma is often cited by papers focused on Extracellular vesicles in disease (9 papers), Immunotherapy and Immune Responses (8 papers) and Immune cells in cancer (8 papers). Qingle Ma collaborates with scholars based in China, United States and Japan. Qingle Ma's co-authors include Chao Wang, Jialu Xu, Qin Fan, Zhuang Liu, Huaxing Dai, Jinyu Bai, Ziying Fei, Yue Zhang, Ziliang Dong and Xiao Han and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Qingle Ma

31 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingle Ma China 18 556 509 364 193 154 31 1.3k
Huaxing Dai China 16 436 0.8× 510 1.0× 319 0.9× 154 0.8× 151 1.0× 38 1.1k
Jialu Xu China 21 782 1.4× 608 1.2× 461 1.3× 208 1.1× 193 1.3× 56 1.7k
Guo‐Chung Dong Taiwan 18 641 1.2× 407 0.8× 169 0.5× 339 1.8× 343 2.2× 41 1.6k
Ni Jiang China 21 336 0.6× 433 0.9× 230 0.6× 307 1.6× 448 2.9× 88 1.3k
Taiyoun Rhim South Korea 29 742 1.3× 225 0.4× 350 1.0× 139 0.7× 216 1.4× 68 2.1k
Manuela Rizzi Italy 20 490 0.9× 217 0.4× 267 0.7× 115 0.6× 140 0.9× 67 1.5k
Lingling Ou China 15 304 0.5× 696 1.4× 134 0.4× 98 0.5× 175 1.1× 32 1.3k
Yawen Xu China 21 325 0.6× 277 0.5× 70 0.2× 119 0.6× 196 1.3× 80 1.3k
Xueli Mao China 19 484 0.9× 331 0.7× 161 0.4× 62 0.3× 152 1.0× 52 1.1k
Xin Chang China 14 422 0.8× 458 0.9× 137 0.4× 111 0.6× 183 1.2× 36 1.1k

Countries citing papers authored by Qingle Ma

Since Specialization
Citations

This map shows the geographic impact of Qingle Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingle Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingle Ma more than expected).

Fields of papers citing papers by Qingle Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingle Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingle Ma. The network helps show where Qingle Ma may publish in the future.

Co-authorship network of co-authors of Qingle Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Qingle Ma. A scholar is included among the top collaborators of Qingle Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingle Ma. Qingle Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Qingle, Heng Wang, Bingbing Wu, et al.. (2025). Targeting myeloid cells with platelet-derived extracellular vesicles to overcome resistance of immune checkpoint blockade therapy. Biomaterials. 321. 123336–123336. 3 indexed citations
2.
Xu, Jialu, Yue Zhang, Huaxing Dai, et al.. (2024). Oral administration of garlic-derived nanoparticles improves cancer immunotherapy by inducing intestinal IFNγ-producing γδ T cells. Nature Nanotechnology. 19(10). 1569–1578. 32 indexed citations
3.
Ma, Qingle, Yi Wu, Heng Wang, et al.. (2023). Neurological disorders after severe pneumonia are associated with translocation of endogenous bacteria from the lung to the brain. Science Advances. 9(42). 13 indexed citations
4.
Ma, Qingle, Jialu Xu, Bo Tian, et al.. (2023). Severe pneumonia induces immunosenescence of T cells in the lung of mice. Aging. 15(14). 7084–7097. 3 indexed citations
5.
Xu, Fang, Jialu Xu, Huaxing Dai, et al.. (2023). Engineering of dendritic cell bispecific extracellular vesicles for tumor-targeting immunotherapy. Cell Reports. 42(10). 113138–113138. 20 indexed citations
6.
Yang, Qianyu, Huaxing Dai, Ying Cheng, et al.. (2023). Oral feeding of nanoplastics affects brain function of mice by inducing macrophage IL-1 signal in the intestine. Cell Reports. 42(4). 112346–112346. 81 indexed citations
7.
Xu, Jialu, Qingle Ma, Yue Zhang, et al.. (2022). Yeast-derived nanoparticles remodel the immunosuppressive microenvironment in tumor and tumor-draining lymph nodes to suppress tumor growth. Nature Communications. 13(1). 110–110. 90 indexed citations
8.
Dai, Huaxing, Qianyu Yang, Rong Sun, et al.. (2022). Nanoparticle accumulation in liver may induce resistance to immune checkpoint blockade therapy. Nano Research. 16(4). 5237–5246. 5 indexed citations
9.
Wang, Beilei, Jinyu Bai, Bo Tian, et al.. (2022). Genetically Engineered Hematopoietic Stem Cells Deliver TGF‐β Inhibitor to Enhance Bone Metastases Immunotherapy. Advanced Science. 9(28). e2201451–e2201451. 18 indexed citations
10.
Ma, Qingle, Jinyu Bai, Jialu Xu, et al.. (2021). Reshaping the Inflammatory Environment in Rheumatoid Arthritis Joints by Targeting Delivery of Berberine with Platelet‐Derived Extracellular Vesicles. SHILAP Revista de lepidopterología. 1(11). 13 indexed citations
11.
Fan, Qin, Huaxing Dai, Jinyu Bai, et al.. (2021). Degradation-resistant implanted biomaterials establish an immunosuppressive microenvironment that induces T cell exhaustion by recruiting myeloid cells. Fundamental Research. 2(4). 648–658. 11 indexed citations
12.
Fei, Ziying, Qin Fan, Huaxing Dai, et al.. (2021). Physiologically triggered injectable red blood cell-based gel for tumor photoablation and enhanced cancer immunotherapy. Biomaterials. 271. 120724–120724. 41 indexed citations
13.
Dai, Huaxing, Qin Fan, Ziying Fei, et al.. (2021). Systemically administered silica nanoparticles result in diminished T cell response in lung. Nano Today. 42. 101332–101332. 10 indexed citations
14.
Ma, Qingle, Jinyu Bai, Jialu Xu, et al.. (2021). Reshaping the Inflammatory Environment in Rheumatoid Arthritis Joints by Targeting Delivery of Berberine with Platelet‐Derived Extracellular Vesicles. SHILAP Revista de lepidopterología. 1(11). 17 indexed citations
15.
Shen, Shufang, Huaxing Dai, Ziying Fei, et al.. (2021). Immunosuppressive Nanoparticles for Management of Immune-Related Adverse Events in Liver. ACS Nano. 15(5). 9111–9125. 37 indexed citations
16.
Fan, Qin, Qingle Ma, Jialu Xu, et al.. (2020). An implantable blood clot–based immune niche for enhanced cancer vaccination. Science Advances. 6(39). 78 indexed citations
17.
Ma, Qingle, Qin Fan, Jialu Xu, et al.. (2020). Calming Cytokine Storm in Pneumonia by Targeted Delivery of TPCA-1 Using Platelet-Derived Extracellular Vesicles. Matter. 3(1). 287–301. 150 indexed citations
18.
Ma, Qingle, Qin Fan, Xiao Han, et al.. (2020). Platelet-derived extracellular vesicles to target plaque inflammation for effective anti-atherosclerotic therapy. Journal of Controlled Release. 329. 445–453. 86 indexed citations
19.
Han, Xiao, Jiawen Chen, Jiacheng Chu, et al.. (2019). Platelets as platforms for inhibition of tumor recurrence post-physical therapy by delivery of anti-PD-L1 checkpoint antibody. Journal of Controlled Release. 304. 233–241. 81 indexed citations
20.
Bai, Jinyu, Yingzi Zhang, Qin Fan, et al.. (2019). Reactive Oxygen Species‐Scavenging Scaffold with Rapamycin for Treatment of Intervertebral Disk Degeneration. Advanced Healthcare Materials. 9(3). e1901186–e1901186. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huaxing Dai Breakdown of academic impact, for papers by Jialu Xu Breakdown of academic impact, for papers by Guo‐Chung Dong Breakdown of academic impact, for papers by Ni Jiang Breakdown of academic impact, for papers by Taiyoun Rhim Breakdown of academic impact, for papers by Manuela Rizzi Breakdown of academic impact, for papers by Lingling Ou Breakdown of academic impact, for papers by Yawen Xu Breakdown of academic impact, for papers by Xueli Mao Breakdown of academic impact, for papers by Xin Chang
Rankless by CCL
2026